Burning mouth syndrome caused by xerostomia secondary to amlodipine
Open Access
- 1 December 2020
- journal article
- Published by Universitas Airlangga in Dental Journal (Majalah Kedokteran Gigi)
Abstract
Background: Xerostomia, generally referred to as dry mouth, has been identified as a side effect of more than 1,800 drugs from more than 80 groups. This condition is frequently unrecognised and untreated but may affect patients’ quality of life and cause problems with oral and medical health, including burning mouth syndrome (BMS). Purpose: The purpose of this case is to discuss how to manage a patient with BMS caused by xerostomia secondary to medication that has been taken by the patient. Case: We reported that a 45-year-old male military officer from the Royal Malaysian Air Force came to Kuching Armed Forces Dental Clinic with dry mouth and a burning sensation since he started taking 10 mg of amlodipine due to his hypertension. After a thorough physical and history examination, we made a diagnosis of burning mouth syndrome (BMS) caused by xerostomia secondary to amlodipine. Case Management: Oral hygiene instructions, diet advice and prescription of Oral7 mouthwash has been given to reduce the symptoms of BMS. The patient has been referred to the general practitioner to reduce his amlodipine dosage from 10 mg to 5 mg (OD) in order to prevent xerostomia, and oral hygiene instructions have been given. A review after two weeks showed significant changes in the oral cavity, and the patient was satisfied as he is no longer feeling the burning sensation and can enjoy his food without feeling difficulty in chewing and swallowing. Conclusion: Adverse drug events are normal in the oral cavity and may have a number of clinical presentations such as xerostomia. Xerostomia can cause many implications as saliva helps in maintaining oral mucosa and has a protective function. The signs of adverse drug incidents in the oral cavity should be identified to oral health care professionals.Keywords
This publication has 15 references indexed in Scilit:
- Burning mouth syndromeCephalalgia, 2017
- Hyposalivation and XerostomiaDental Clinics of North America, 2016
- Anticholinergics: theoretical and clinical overviewExpert Opinion on Drug Safety, 2016
- Different methods, different results—how do available methods link a patient’s anticholinergic load with adverse outcomes?European Journal of Clinical Pharmacology, 2015
- Xerostomia: Understanding the Diagnosis and the Treatment of Dry MouthJournal of Family Medicine and Disease Prevention, 2015
- Dry mouth and older peopleAustralian Dental Journal, 2015
- Salivary hypofunction: An update on aetiology, diagnosis and therapeuticsArchives of Oral Biology, 2015
- A comparison of salivary substitutes versus a natural sialogogue (citric acid) in patients complaining of dry mouth as an adverse drug reaction: a clinical, randomized controlled studyOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2011
- Burning mouth syndrome: An updateMedicina Oral Patología Oral y Cirugia Bucal, 2010
- Síndrome da boca ardente: etiologiaRevista Brasileira de Otorrinolaringologia, 2006